Knurr v. Orbital ATK Inc.

272 F. Supp. 3d 784
District Court, E.D. Virginia·Decided September 26, 2017·No. Case No. 1:16-cv-1031·Published·Cited by 1 cases

Opinion

MEMORANDUM OPINION I

T. S. Ellis, III, United States District Judge

Plaintiffs in this federal securities class action allege claims under (i) § 10(b) and Rule 10b-5; (ii) § 14(a) and Rule 14a-9; and (iii) § 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”). Defendants seek threshold dismissal of claims under all three provisions, and a separate memorandum opinion addresses the § 14(a) and related § 20(a) claims. This memorandum opinion addresses the questions presented under § 10(b) and the related § 20(a) claims, which are as follows:

(1) whether plaintiffs have alleged facts in the Complaint1 that warrant, as the Private Securities Litigation- Reform Act (“PSLRA”) requires, a “strong inference” of scienter with respect to their claim under § 10(b) of the Exchange Act that defendants, a publicly traded aerospace and defense company and four of its high-level officers, intentionally concealed or recklessly ignored significant losses on a government contract; and
(2) whether under § 20(a) of the. Exchange Act, the Complaint adequately alleges that the defendants had control oven any person liable under § 10(b) of the Exchange Act. Parties have fully briefed and argued these questions, and they are ripe for disposition.

I.

Before reciting the pertinent facts, it is important to identify the proper source of those facts.’ First, as the parties agree and as settled precedent requires, the facts recited here are taken chiefly from the Complaint’s factual allegations, which must be accepted as true at this stage. Cozzarelli v. Inspire Pharm. Inc., 549 F.3d 618, 625 (4th Cir. 2008) (noting that at the motion to dismiss stage, “we must accept plaintiffs’ factual allegations as true”). Defendants have also sought to have additional facts considered by attaching various exhibits to the motion to dismiss.2 Only certain of these documents are appropriately considered at this stage.

Settled circuit authority permits courts to consider external documents in a motion to dismiss when they “are integral to and explicitly relied on in the complaint, and when the plaintiffs do not challenge the document’s authenticity.” Zak v. Chelsea Therapeutics Int’l, Ltd., 780 F.3d 597, 606-07 (4th Cir. 2015) (quotation marks and brackets omitted). The SEC filings attached to defendants’ dismissal motion, the transcripts of the August 10, 2016, November 8, 2016, and March 8, 2017 Orbital ATK conference calls, and the Wells Fargo and Barclays analyst reports are integral to or explicitly referenced in the Complaint, and plaintiffs do not challenge their, authenticity. Accordingly, these documents are appropriately considered at this stage. Similarly, because the Fourth Circuit permits courts to take “judicial notice of published stock prices without converting .a motion to dismiss into a motion for summary judgment,” it is also appropriate to consider the chart summarizing Orbital ATK’s historical stock prices. Greenhouse v. MCG Capital Corp., 392 F.3d 650, 655 (4th Cir. 2004). By contrast, Alliant’s August 1, 2013 conference call is not referenced in the Complaint, nor does the Complaint cite the KeyBank analyst report, so it is inappropriate to consider these documents at the motion to dismiss stage.

II.

Corporate defendant, Orbital ATK, is an aerospace and defense company headquartered in Dulles, Virginia. The company’s stock trades on the New York Stock Exchange under the ticker symbol “OA.” Orbital ATK was formed out of the February 2015 merger between two companies — Orbital-Sciences Corporation (“Orbital Sciences”) and Alliant Techsystems,- Inc. (“Al-liant”).

In' addition to the corporate defendant, the Complaint names the following four individual defendants:

(1) David D. Thompson;
(2) Garrett E. Pierce;
(3) Blake E. Larson; and
(4) Mark DeYoung.

Defendant Thompson has been the Chief Executive Officer and President of Orbital ATK since the merger; before the merger, he was the Chairman of the Board, CEO, and President of Orbital Sciences. Defendant Pierce is currently Orbital ATK’s Chief Financial Officer; before the mei’ger he was Vice Chairman of the Board and CFO of Orbital Sciences. Defendant Larson is the Chief Operating Officer of Orbital ATK; before the merger he was the Senior Vice President of Alliant and President of Alliant’s Aerospace Group. Finally, defendant DeYoung was a Director of Orbital’ATK from the merger until March 2016; before the merger he served as the CEO and President of Alliant.

Plaintiffs allege that Thompson, Pierce, and Larson made a number of false and misleading statements with respect to the financial success of Orbital ATK after the merger of Orbital ATK’s predecessor companies, Orbital Sciences and Alliant. In particular, plaintiffs focus on Thompson, Pierce, DeYoung and Larson’s failure to disclose for over a year that a major ammunition contract with the United States Army — the Lake City Contract — was costing Orbital ATK hundreds of millions of dollars. Under Orbital ATK’s own accounting policy and Generally Accepted Principles of Accounting (“GAAP”), gross estimated losses on long-term contracts such as the Lake City Contract must be disclosed and recorded as soon as such losses become evident. On August 10, .2016, Thompson, Pierce, and Larson announced that they would be restating several of Orbital ATK’s financial statements to reflect nearly $400 million in losses on the Army ammunition contract, and also announced that the losses from this contract should have been recorded earlier pursuant to the, accounting policy and GAAP. Defendants’ alleged cover-up of the losses on the ammunition contract form the basis of plaintiffs’ claims under § 10(b) of the Exchange Act.

Prior to their merger, Orbital Sciences and Alliant were both publicly traded aerospace and defense’ companies headquartered in Virginia and both sold products such as rockets and satellites to NASA and the United States military. Alliant'was also a leading ammunition producer for the United States military; Orbital Sciences did not manufacture or sell ammunition. Both companies relied heavily on government contracts, which were 70% of Affi-ant's sales and 80% of Orbital Sciences’ sales. At the same time, the Complaint alleges that heading into the merger, Alli-ant was under pressure to renew a major ammunition contract, and Orbital Sciences was dealing with a series of financial missteps. The Complaint alleges that these pressures set the stage for defendants’ fraudulent and misleading statements with respect to Orbital ATK’s post-merger financial performance.

With respect to Alliant, plaintiffs’ claims focus on the Lake City Contract between Alliant and the United States Army, which Alliant originally entered into in 2000.

Free access — add to your briefcase to read the full text and ask questions with AI

Knurr v. Orbital ATK Inc., 272 F. Supp. 3d 784 (E.D. Va. 2017).

272 F. Supp. 3d 784 (Knurr v. Orbital ATK Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Knurr v. Orbital Atk Inc.
294 F. Supp. 3d 498 (E.D. Virginia, 2018)